Login
From:
Parkinson's News Today
(Uncensored)
subscribe
1st patient dosed in Phase 2 trial of Parkinson's therapy VTX3232
https://parkinsonsnewstoday.com/news/1st-patient-dosed-phase-2-trial-parkinsons-therapy-vtx-3232/
links
backlinks
Tagged with:
clinical trial
nlrp3
The first patient has been dosed in a Phase 2a trial of Parkinson's therapy VTX3232, an oral medication designed to reduce inflammation.
Roast topics
Find topics
Find it!
